Posted in | News | Automotive Sensors

Smart Eye Wins Largest Driver Monitoring System (DMS) Deal to Date

Smart Eye, the leading developer of DMS software to the automotive industry, has received 34 design wins from two existing and one new OEM customer. The car manufacturers belong to a European-American automotive alliance, which constitutes one of the largest vehicle producers in the world.
The new nomination means Smart Eye will deliver its AI-based driver monitoring system software to 34 new car models to fulfill upcoming European legislation. The models to include Smart Eye’s technology will start going into production in 2025 and be fully ramped up by 2026. Most of the 34 models are updates of existing production programs. After 2026 they will gradually be replaced with new vehicles launched on new platforms. The estimated revenue for the order is SEK 350 million, based on product life cycle volume projections.

“In terms of number of new car models, this is the biggest deal in the history of DMS – so far”, said Martin Krantz, CEO and Founder of Smart Eye. “The date for when the European legislation kicks in is a hard stop. In 2026 we estimate the European market for DMS to be 18 million vehicles. This latest contract constitutes a large chunk of that volume. We have for some time indicated that big OEM procurements are settled and will be communicated. This is one of them.”

Smart Eye has now received a total of 141 design wins from 17 OEMs. The combined estimated lifetime value from current design wins is now larger than 3,035 billion. Estimated value over the product lifecycle from possible additional design wins with the car manufacturers on existing platforms is now SEK 4,075 billion.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.